FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104495093> ?p ?o ?g. }

• W2104495093 endingPage "219" @default.
• W2104495093 startingPage "213" @default.
• W2104495093 abstract "Even after the introduction of all-trans retinoic acid (ATRA), early hemorrhagic death remains a major cause of remission induction failure for acute promyelocytic leukemia (APL).To investigate severe hemorrhagic complications during remission induction therapy with respect to incidence, risk factors, and influence on outcome. Results were analyzed for 279 patients enrolled in the APL97 study conducted by the Japan Adult Leukemia Study Group (JALSG).Severe hemorrhage occurred in 18 patients (6.5%). Although most of them were receiving frequent transfusions, the targeted levels of platelet counts (30 x 10(9)/L) and plasma fibrinogen (1.5 g/L) for this study were reached at the day of bleeding in only 71% and 40%, respectively. Nine of them succumbed to an early death, while the remaining nine patients eventually achieved complete remission (CR). The 5-yr event-free survival rate was 68.1% for those who did not suffer severe hemorrhage, and 31.1% for those who did (P < 0.0001). For patients who achieved CR, on the other hand, there was no difference in disease-free survival between patients with and without severe hemorrhage (P = 0.6043). Risk factor analysis identified three pretreatment variables associated with severe hemorrhage: initial fibrinogen level, white blood cell count, and performance status. Additionally, patients with severe hemorrhage were more easily prone to develop retinoic acid syndrome or pneumonia than patients without hemorrhage.These results indicate that fatal hemorrhage represents a major obstacle in curing APL, and that patients with such high-risk features may benefit from more aggressive supportive care." @default.
• W2104495093 created "2016-06-24" @default.
• W2104495093 creator A5001496361 @default.
• W2104495093 creator A5009994116 @default.
• W2104495093 creator A5011041172 @default.
• W2104495093 creator A5013146671 @default.
• W2104495093 creator A5017994748 @default.
• W2104495093 creator A5024134742 @default.
• W2104495093 creator A5037362999 @default.
• W2104495093 creator A5045270299 @default.
• W2104495093 creator A5047434427 @default.
• W2104495093 creator A5063488239 @default.
• W2104495093 creator A5069047580 @default.
• W2104495093 creator A5070390821 @default.
• W2104495093 creator A5070702322 @default.
• W2104495093 creator A5072046575 @default.
• W2104495093 creator A5077332581 @default.
• W2104495093 creator A5078192175 @default.
• W2104495093 creator A5084655190 @default.
• W2104495093 date "2006-12-19" @default.
• W2104495093 modified "2023-10-12" @default.
• W2104495093 title "Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome" @default.
• W2104495093 cites W1515269506 @default.
• W2104495093 cites W1894820534 @default.
• W2104495093 cites W2004459277 @default.
• W2104495093 cites W2050863148 @default.
• W2104495093 cites W2085251563 @default.
• W2104495093 cites W2087429704 @default.
• W2104495093 cites W2091129902 @default.
• W2104495093 cites W2138630072 @default.
• W2104495093 cites W2162974504 @default.
• W2104495093 cites W2334200141 @default.
• W2104495093 cites W2414768692 @default.
• W2104495093 cites W2430156720 @default.
• W2104495093 cites W4232020126 @default.
• W2104495093 cites W78907138 @default.
• W2104495093 cites W79968274 @default.
• W2104495093 doi "https://doi.org/10.1111/j.1600-0609.2006.00803.x" @default.
• W2104495093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17241371" @default.
• W2104495093 hasPublicationYear "2006" @default.
• W2104495093 type Work @default.
• W2104495093 sameAs 2104495093 @default.
• W2104495093 citedByCount "110" @default.
• W2104495093 countsByYear W21044950932012 @default.
• W2104495093 countsByYear W21044950932013 @default.
• W2104495093 countsByYear W21044950932014 @default.
• W2104495093 countsByYear W21044950932015 @default.
• W2104495093 countsByYear W21044950932016 @default.
• W2104495093 countsByYear W21044950932017 @default.
• W2104495093 countsByYear W21044950932018 @default.
• W2104495093 countsByYear W21044950932019 @default.
• W2104495093 countsByYear W21044950932020 @default.
• W2104495093 countsByYear W21044950932021 @default.
• W2104495093 countsByYear W21044950932022 @default.
• W2104495093 countsByYear W21044950932023 @default.
• W2104495093 crossrefType "journal-article" @default.
• W2104495093 hasAuthorship W2104495093A5001496361 @default.
• W2104495093 hasAuthorship W2104495093A5009994116 @default.
• W2104495093 hasAuthorship W2104495093A5011041172 @default.
• W2104495093 hasAuthorship W2104495093A5013146671 @default.
• W2104495093 hasAuthorship W2104495093A5017994748 @default.
• W2104495093 hasAuthorship W2104495093A5024134742 @default.
• W2104495093 hasAuthorship W2104495093A5037362999 @default.
• W2104495093 hasAuthorship W2104495093A5045270299 @default.
• W2104495093 hasAuthorship W2104495093A5047434427 @default.
• W2104495093 hasAuthorship W2104495093A5063488239 @default.
• W2104495093 hasAuthorship W2104495093A5069047580 @default.
• W2104495093 hasAuthorship W2104495093A5070390821 @default.
• W2104495093 hasAuthorship W2104495093A5070702322 @default.
• W2104495093 hasAuthorship W2104495093A5072046575 @default.
• W2104495093 hasAuthorship W2104495093A5077332581 @default.
• W2104495093 hasAuthorship W2104495093A5078192175 @default.
• W2104495093 hasAuthorship W2104495093A5084655190 @default.
• W2104495093 hasConcept C104317684 @default.
• W2104495093 hasConcept C120665830 @default.
• W2104495093 hasConcept C121332964 @default.
• W2104495093 hasConcept C126322002 @default.
• W2104495093 hasConcept C141071460 @default.
• W2104495093 hasConcept C185592680 @default.
• W2104495093 hasConcept C2776601000 @default.
• W2104495093 hasConcept C2777050789 @default.
• W2104495093 hasConcept C2777714996 @default.
• W2104495093 hasConcept C2777914695 @default.
• W2104495093 hasConcept C2778488018 @default.
• W2104495093 hasConcept C2779036427 @default.
• W2104495093 hasConcept C2781121885 @default.
• W2104495093 hasConcept C55493867 @default.
• W2104495093 hasConcept C61511704 @default.
• W2104495093 hasConcept C71924100 @default.
• W2104495093 hasConcept C90924648 @default.
• W2104495093 hasConceptScore W2104495093C104317684 @default.
• W2104495093 hasConceptScore W2104495093C120665830 @default.
• W2104495093 hasConceptScore W2104495093C121332964 @default.
• W2104495093 hasConceptScore W2104495093C126322002 @default.
• W2104495093 hasConceptScore W2104495093C141071460 @default.
• W2104495093 hasConceptScore W2104495093C185592680 @default.
• W2104495093 hasConceptScore W2104495093C2776601000 @default.
• W2104495093 hasConceptScore W2104495093C2777050789 @default.

• next